Home

Akums Drugs & Pharmaceuticals Ltd 52 Week High

Image

Akums Drugs & Pharmaceuticals Ltd

NSE: AKUMS

YEARHIGH

₹ 1174.85

Last updated on: Feb 21, 2025

Key Highlights

  • The 52 Week HIGH of Akums Drugs & Pharmaceuticals Ltd is ₹ 1174 as of 21 Feb 25 .

Company Fundamentals for Akums Drugs & Pharmaceuticals Ltd

Market Price of Akums Drugs & Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Akums Drugs & Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Feb 2025496.45
20 Feb 2025511.75
19 Feb 2025494.7
18 Feb 2025501.8
17 Feb 2025516.1
14 Feb 2025524.3
13 Feb 2025550.15
12 Feb 2025549.55
11 Feb 2025541.4
10 Feb 2025571.25

Asset Value vs Market Value of Akums Drugs & Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Historical Revenue of Akums Drugs & Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Akums Drugs & Pharmaceuticals Ltd

No data available

* All values are in crore

Akums Drugs & Pharmaceuticals Ltd News Hub

Akums Drugs and Pharmaceuticals rises on debut

The scrip was listed at Rs 725, exhibiting a 6.77% premium to the issue price. So far, the stock has

Read more

06 Aug 24

Akums Drugs and Pharmaceuticals IPO ends with strong subscription

The initial public offer (IPO) of Akums Drugs and Pharmaceuticals received 96,36,79,134 bids for sha

Read more

02 Aug 24

Akums Drugs and Pharmaceuticals IPO subscribed 63.44 times

The initial public offer (IPO) of Akums Drugs and Pharmaceuticals received 96,18,57,204 bids for sha

Read more

01 Aug 24

Akums Drugs & Pharmaceuticals reports consolidated net profit of Rs 60.17 crore in the June 2024 quarter

Net profit of Akums Drugs & Pharmaceuticals reported to Rs 60.17 crore in the quarter ended June 202

Read more

26 Aug 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of Akums Drugs & Pharmaceuticals Ltd

What is the significance of Akums Drugs & Pharmaceuticals Ltd reaching its 52-week high?

Akums Drugs & Pharmaceuticals Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Akums Drugs & Pharmaceuticals Ltd 52-week high?

Investors monitor Akums Drugs & Pharmaceuticals Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Akums Drugs & Pharmaceuticals Ltd a good buy when it hits its 52-week high?

Whether Akums Drugs & Pharmaceuticals Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Akums Drugs & Pharmaceuticals Ltd fundamentals.

What should I consider before investing in Akums Drugs & Pharmaceuticals Ltd at its 52-week high?

Before investing in Akums Drugs & Pharmaceuticals Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Akums Drugs & Pharmaceuticals Ltd stock price continue to rise after reaching its 52-week high?

Akums Drugs & Pharmaceuticals Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions